Eosinophilic Esophagus (EoE)

SHP621-301

A phase 3, double-blind, placebo-controlled multicenter research study of the effectiveness and safety of an oral investigational study medication in patients with Eosinophilic Esophagitis.

Enrollment Status: OPEN

This is a phase 3 research study for patients with EoE (Eosinophilic Esophagitis) who have evidence of dysphagia. Participants will remain on the study and continue to receive the study investigational medication or placebo until the study is completed. It is estimated that subjects will participate for approximately 26 weeks. During this time, participants will have 6 study visits and one follow up telephone call.

For information about research studies for patients with this condition, call our Research Hotline number at 612-870-5599, OR input the following information and we will follow up with you to discuss your interest:

ATTENTION: This form is not meant for transmitting medical, prescription or appointment information or to initiate direct communications with our health care providers. Calls of this nature will not be answered by email and should be directed to 612-871-1145. In the event of a medical emergency, dial 911. Emails are monitored Monday through Friday during regular business hours.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.